nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfentanil—ORM1—Vemurafenib—melanoma	0.216	0.402	CbGbCtD
Alfentanil—ALB—melanoma	0.2	0.512	CbGaD
Alfentanil—ABCB1—melanoma	0.191	0.488	CbGaD
Alfentanil—ALB—Vemurafenib—melanoma	0.0908	0.169	CbGbCtD
Alfentanil—CYP3A4—Temozolomide—melanoma	0.0519	0.0968	CbGbCtD
Alfentanil—CYP3A7—Docetaxel—melanoma	0.0334	0.0622	CbGbCtD
Alfentanil—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0334	0.0622	CbGbCtD
Alfentanil—ABCB1—Dactinomycin—melanoma	0.0316	0.0588	CbGbCtD
Alfentanil—CYP3A4—Vemurafenib—melanoma	0.0284	0.053	CbGbCtD
Alfentanil—CYP3A5—Docetaxel—melanoma	0.025	0.0467	CbGbCtD
Alfentanil—ABCB1—Docetaxel—melanoma	0.0163	0.0304	CbGbCtD
Alfentanil—CYP3A4—Docetaxel—melanoma	0.00976	0.0182	CbGbCtD
Alfentanil—Injection site pain—Carmustine—melanoma	0.001	0.0203	CcSEcCtD
Alfentanil—Connective tissue disorder—Vemurafenib—melanoma	0.000764	0.0155	CcSEcCtD
Alfentanil—Disorientation—Bleomycin—melanoma	0.000761	0.0154	CcSEcCtD
Alfentanil—Eye disorder—Vemurafenib—melanoma	0.000726	0.0147	CcSEcCtD
Alfentanil—Cardiac disorder—Vemurafenib—melanoma	0.000721	0.0146	CcSEcCtD
Alfentanil—Dermatitis atopic—Docetaxel—melanoma	0.000711	0.0144	CcSEcCtD
Alfentanil—Angiopathy—Vemurafenib—melanoma	0.000705	0.0143	CcSEcCtD
Alfentanil—Mediastinal disorder—Vemurafenib—melanoma	0.000701	0.0142	CcSEcCtD
Alfentanil—Chills—Vemurafenib—melanoma	0.000697	0.0141	CcSEcCtD
Alfentanil—Erythema—Vemurafenib—melanoma	0.000677	0.0137	CcSEcCtD
Alfentanil—Cough—Vemurafenib—melanoma	0.00059	0.0119	CcSEcCtD
Alfentanil—Bronchospasm—Bleomycin—melanoma	0.000579	0.0117	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000572	0.0116	CcSEcCtD
Alfentanil—Anaphylactic shock—Vemurafenib—melanoma	0.000552	0.0112	CcSEcCtD
Alfentanil—Nervous system disorder—Vemurafenib—melanoma	0.000542	0.011	CcSEcCtD
Alfentanil—Skin disorder—Vemurafenib—melanoma	0.000536	0.0109	CcSEcCtD
Alfentanil—Blood pressure increased—Docetaxel—melanoma	0.000526	0.0106	CcSEcCtD
Alfentanil—Hypotension—Vemurafenib—melanoma	0.000516	0.0104	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Vemurafenib—melanoma	0.000477	0.00965	CcSEcCtD
Alfentanil—Fatigue—Vemurafenib—melanoma	0.000476	0.00963	CcSEcCtD
Alfentanil—Body temperature increased—Vemurafenib—melanoma	0.000437	0.00883	CcSEcCtD
Alfentanil—Chills—Bleomycin—melanoma	0.000423	0.00855	CcSEcCtD
Alfentanil—Erythema—Bleomycin—melanoma	0.00041	0.0083	CcSEcCtD
Alfentanil—Hypersensitivity—Vemurafenib—melanoma	0.000407	0.00823	CcSEcCtD
Alfentanil—Connective tissue disorder—Carmustine—melanoma	0.000404	0.00817	CcSEcCtD
Alfentanil—Visual disturbance—Docetaxel—melanoma	0.000403	0.00815	CcSEcCtD
Alfentanil—Asthenia—Vemurafenib—melanoma	0.000396	0.00802	CcSEcCtD
Alfentanil—Visual impairment—Carmustine—melanoma	0.000396	0.00802	CcSEcCtD
Alfentanil—Chills—Dactinomycin—melanoma	0.000394	0.00797	CcSEcCtD
Alfentanil—Pruritus—Vemurafenib—melanoma	0.000391	0.00791	CcSEcCtD
Alfentanil—Connective tissue disorder—Temozolomide—melanoma	0.00039	0.0079	CcSEcCtD
Alfentanil—Eye disorder—Carmustine—melanoma	0.000384	0.00777	CcSEcCtD
Alfentanil—Visual impairment—Temozolomide—melanoma	0.000383	0.00775	CcSEcCtD
Alfentanil—Erythema—Dactinomycin—melanoma	0.000382	0.00774	CcSEcCtD
Alfentanil—Eye disorder—Temozolomide—melanoma	0.000371	0.00751	CcSEcCtD
Alfentanil—Cardiac disorder—Temozolomide—melanoma	0.000369	0.00746	CcSEcCtD
Alfentanil—Arrhythmia—Carmustine—melanoma	0.000367	0.00743	CcSEcCtD
Alfentanil—Dizziness—Vemurafenib—melanoma	0.000365	0.00739	CcSEcCtD
Alfentanil—Angiopathy—Temozolomide—melanoma	0.00036	0.00729	CcSEcCtD
Alfentanil—Mental disorder—Carmustine—melanoma	0.00036	0.00729	CcSEcCtD
Alfentanil—Immune system disorder—Temozolomide—melanoma	0.000359	0.00726	CcSEcCtD
Alfentanil—Mediastinal disorder—Temozolomide—melanoma	0.000358	0.00724	CcSEcCtD
Alfentanil—Erythema—Carmustine—melanoma	0.000358	0.00724	CcSEcCtD
Alfentanil—Cough—Bleomycin—melanoma	0.000358	0.00724	CcSEcCtD
Alfentanil—Chills—Temozolomide—melanoma	0.000356	0.00721	CcSEcCtD
Alfentanil—Vomiting—Vemurafenib—melanoma	0.000351	0.00711	CcSEcCtD
Alfentanil—Rash—Vemurafenib—melanoma	0.000348	0.00705	CcSEcCtD
Alfentanil—Mental disorder—Temozolomide—melanoma	0.000348	0.00704	CcSEcCtD
Alfentanil—Dermatitis—Vemurafenib—melanoma	0.000348	0.00704	CcSEcCtD
Alfentanil—Headache—Vemurafenib—melanoma	0.000346	0.007	CcSEcCtD
Alfentanil—Erythema—Temozolomide—melanoma	0.000346	0.007	CcSEcCtD
Alfentanil—Confusional state—Bleomycin—melanoma	0.000337	0.00683	CcSEcCtD
Alfentanil—Vision blurred—Carmustine—melanoma	0.000337	0.00682	CcSEcCtD
Alfentanil—Anaphylactic shock—Bleomycin—melanoma	0.000335	0.00677	CcSEcCtD
Alfentanil—Agitation—Carmustine—melanoma	0.000329	0.00665	CcSEcCtD
Alfentanil—Nausea—Vemurafenib—melanoma	0.000328	0.00664	CcSEcCtD
Alfentanil—Vision blurred—Temozolomide—melanoma	0.000326	0.00659	CcSEcCtD
Alfentanil—Bronchospasm—Docetaxel—melanoma	0.000325	0.00657	CcSEcCtD
Alfentanil—Agitation—Temozolomide—melanoma	0.000318	0.00643	CcSEcCtD
Alfentanil—Hypotension—Bleomycin—melanoma	0.000313	0.00633	CcSEcCtD
Alfentanil—Convulsion—Carmustine—melanoma	0.00031	0.00627	CcSEcCtD
Alfentanil—Hypertension—Carmustine—melanoma	0.000309	0.00625	CcSEcCtD
Alfentanil—Cough—Temozolomide—melanoma	0.000302	0.00611	CcSEcCtD
Alfentanil—Convulsion—Temozolomide—melanoma	0.0003	0.00606	CcSEcCtD
Alfentanil—Hypertension—Temozolomide—melanoma	0.000299	0.00604	CcSEcCtD
Alfentanil—Confusional state—Carmustine—melanoma	0.000294	0.00596	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000292	0.00592	CcSEcCtD
Alfentanil—Pain—Bleomycin—melanoma	0.000286	0.00579	CcSEcCtD
Alfentanil—Tachycardia—Carmustine—melanoma	0.000285	0.00577	CcSEcCtD
Alfentanil—Confusional state—Temozolomide—melanoma	0.000285	0.00576	CcSEcCtD
Alfentanil—Anaphylactic shock—Temozolomide—melanoma	0.000282	0.00571	CcSEcCtD
Alfentanil—Epistaxis—Docetaxel—melanoma	0.000278	0.00562	CcSEcCtD
Alfentanil—Nervous system disorder—Temozolomide—melanoma	0.000277	0.0056	CcSEcCtD
Alfentanil—Feeling abnormal—Bleomycin—melanoma	0.000276	0.00558	CcSEcCtD
Alfentanil—Skin disorder—Temozolomide—melanoma	0.000274	0.00555	CcSEcCtD
Alfentanil—Hypotension—Carmustine—melanoma	0.000273	0.00552	CcSEcCtD
Alfentanil—Hyperhidrosis—Temozolomide—melanoma	0.000273	0.00552	CcSEcCtD
Alfentanil—Fatigue—Dactinomycin—melanoma	0.000269	0.00544	CcSEcCtD
Alfentanil—Pain—Dactinomycin—melanoma	0.000267	0.0054	CcSEcCtD
Alfentanil—Urticaria—Bleomycin—melanoma	0.000266	0.00538	CcSEcCtD
Alfentanil—Body temperature increased—Bleomycin—melanoma	0.000264	0.00535	CcSEcCtD
Alfentanil—Somnolence—Carmustine—melanoma	0.00026	0.00525	CcSEcCtD
Alfentanil—Connective tissue disorder—Docetaxel—melanoma	0.00026	0.00525	CcSEcCtD
Alfentanil—Feeling abnormal—Dactinomycin—melanoma	0.000257	0.0052	CcSEcCtD
Alfentanil—Visual impairment—Docetaxel—melanoma	0.000255	0.00515	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Carmustine—melanoma	0.000252	0.0051	CcSEcCtD
Alfentanil—Somnolence—Temozolomide—melanoma	0.000251	0.00508	CcSEcCtD
Alfentanil—Pain—Carmustine—melanoma	0.00025	0.00505	CcSEcCtD
Alfentanil—Eye disorder—Docetaxel—melanoma	0.000247	0.005	CcSEcCtD
Alfentanil—Body temperature increased—Dactinomycin—melanoma	0.000247	0.00499	CcSEcCtD
Alfentanil—Hypersensitivity—Bleomycin—melanoma	0.000246	0.00499	CcSEcCtD
Alfentanil—Cardiac disorder—Docetaxel—melanoma	0.000245	0.00496	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Temozolomide—melanoma	0.000244	0.00493	CcSEcCtD
Alfentanil—Fatigue—Temozolomide—melanoma	0.000243	0.00492	CcSEcCtD
Alfentanil—Pain—Temozolomide—melanoma	0.000241	0.00488	CcSEcCtD
Alfentanil—Feeling abnormal—Carmustine—melanoma	0.000241	0.00487	CcSEcCtD
Alfentanil—Asthenia—Bleomycin—melanoma	0.00024	0.00486	CcSEcCtD
Alfentanil—Angiopathy—Docetaxel—melanoma	0.00024	0.00485	CcSEcCtD
Alfentanil—Immune system disorder—Docetaxel—melanoma	0.000239	0.00483	CcSEcCtD
Alfentanil—Mediastinal disorder—Docetaxel—melanoma	0.000238	0.00482	CcSEcCtD
Alfentanil—Chills—Docetaxel—melanoma	0.000237	0.0048	CcSEcCtD
Alfentanil—Pruritus—Bleomycin—melanoma	0.000237	0.00479	CcSEcCtD
Alfentanil—Arrhythmia—Docetaxel—melanoma	0.000236	0.00478	CcSEcCtD
Alfentanil—Feeling abnormal—Temozolomide—melanoma	0.000233	0.00471	CcSEcCtD
Alfentanil—Mental disorder—Docetaxel—melanoma	0.000231	0.00468	CcSEcCtD
Alfentanil—Body temperature increased—Carmustine—melanoma	0.000231	0.00467	CcSEcCtD
Alfentanil—Erythema—Docetaxel—melanoma	0.00023	0.00465	CcSEcCtD
Alfentanil—Hypersensitivity—Dactinomycin—melanoma	0.00023	0.00465	CcSEcCtD
Alfentanil—Urticaria—Temozolomide—melanoma	0.000224	0.00454	CcSEcCtD
Alfentanil—Asthenia—Dactinomycin—melanoma	0.000224	0.00453	CcSEcCtD
Alfentanil—Body temperature increased—Temozolomide—melanoma	0.000223	0.00451	CcSEcCtD
Alfentanil—Hypersensitivity—Carmustine—melanoma	0.000215	0.00435	CcSEcCtD
Alfentanil—Vomiting—Bleomycin—melanoma	0.000213	0.0043	CcSEcCtD
Alfentanil—Rash—Bleomycin—melanoma	0.000211	0.00427	CcSEcCtD
Alfentanil—Dermatitis—Bleomycin—melanoma	0.000211	0.00426	CcSEcCtD
Alfentanil—Asthenia—Carmustine—melanoma	0.00021	0.00424	CcSEcCtD
Alfentanil—Hypersensitivity—Temozolomide—melanoma	0.000208	0.00421	CcSEcCtD
Alfentanil—Asthenia—Temozolomide—melanoma	0.000202	0.0041	CcSEcCtD
Alfentanil—Loss of consciousness—Docetaxel—melanoma	0.000202	0.00409	CcSEcCtD
Alfentanil—Cough—Docetaxel—melanoma	0.000201	0.00406	CcSEcCtD
Alfentanil—Pruritus—Temozolomide—melanoma	0.0002	0.00404	CcSEcCtD
Alfentanil—Convulsion—Docetaxel—melanoma	0.000199	0.00403	CcSEcCtD
Alfentanil—Nausea—Bleomycin—melanoma	0.000199	0.00402	CcSEcCtD
Alfentanil—Hypertension—Docetaxel—melanoma	0.000199	0.00402	CcSEcCtD
Alfentanil—Vomiting—Dactinomycin—melanoma	0.000198	0.00401	CcSEcCtD
Alfentanil—Rash—Dactinomycin—melanoma	0.000197	0.00398	CcSEcCtD
Alfentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000194	0.00393	CcSEcCtD
Alfentanil—Dizziness—Carmustine—melanoma	0.000193	0.00391	CcSEcCtD
Alfentanil—Confusional state—Docetaxel—melanoma	0.000189	0.00383	CcSEcCtD
Alfentanil—Anaphylactic shock—Docetaxel—melanoma	0.000188	0.0038	CcSEcCtD
Alfentanil—Dizziness—Temozolomide—melanoma	0.000187	0.00378	CcSEcCtD
Alfentanil—Vomiting—Carmustine—melanoma	0.000186	0.00376	CcSEcCtD
Alfentanil—Nausea—Dactinomycin—melanoma	0.000185	0.00375	CcSEcCtD
Alfentanil—Rash—Carmustine—melanoma	0.000184	0.00373	CcSEcCtD
Alfentanil—Nervous system disorder—Docetaxel—melanoma	0.000184	0.00372	CcSEcCtD
Alfentanil—Dermatitis—Carmustine—melanoma	0.000184	0.00372	CcSEcCtD
Alfentanil—Tachycardia—Docetaxel—melanoma	0.000183	0.00371	CcSEcCtD
Alfentanil—Headache—Carmustine—melanoma	0.000183	0.0037	CcSEcCtD
Alfentanil—Skin disorder—Docetaxel—melanoma	0.000182	0.00369	CcSEcCtD
Alfentanil—Vomiting—Temozolomide—melanoma	0.000179	0.00363	CcSEcCtD
Alfentanil—Rash—Temozolomide—melanoma	0.000178	0.0036	CcSEcCtD
Alfentanil—Dermatitis—Temozolomide—melanoma	0.000178	0.0036	CcSEcCtD
Alfentanil—Headache—Temozolomide—melanoma	0.000177	0.00358	CcSEcCtD
Alfentanil—Hypotension—Docetaxel—melanoma	0.000175	0.00355	CcSEcCtD
Alfentanil—Nausea—Carmustine—melanoma	0.000173	0.00351	CcSEcCtD
Alfentanil—Nausea—Temozolomide—melanoma	0.000168	0.00339	CcSEcCtD
Alfentanil—Somnolence—Docetaxel—melanoma	0.000167	0.00338	CcSEcCtD
Alfentanil—Gastrointestinal disorder—Docetaxel—melanoma	0.000162	0.00328	CcSEcCtD
Alfentanil—Fatigue—Docetaxel—melanoma	0.000162	0.00327	CcSEcCtD
Alfentanil—Pain—Docetaxel—melanoma	0.00016	0.00325	CcSEcCtD
Alfentanil—Feeling abnormal—Docetaxel—melanoma	0.000155	0.00313	CcSEcCtD
Alfentanil—Body temperature increased—Docetaxel—melanoma	0.000148	0.003	CcSEcCtD
Alfentanil—Hypersensitivity—Docetaxel—melanoma	0.000138	0.0028	CcSEcCtD
Alfentanil—Asthenia—Docetaxel—melanoma	0.000135	0.00272	CcSEcCtD
Alfentanil—Pruritus—Docetaxel—melanoma	0.000133	0.00269	CcSEcCtD
Alfentanil—Dizziness—Docetaxel—melanoma	0.000124	0.00251	CcSEcCtD
Alfentanil—Vomiting—Docetaxel—melanoma	0.000119	0.00241	CcSEcCtD
Alfentanil—Rash—Docetaxel—melanoma	0.000118	0.00239	CcSEcCtD
Alfentanil—Dermatitis—Docetaxel—melanoma	0.000118	0.00239	CcSEcCtD
Alfentanil—Headache—Docetaxel—melanoma	0.000118	0.00238	CcSEcCtD
Alfentanil—Nausea—Docetaxel—melanoma	0.000111	0.00226	CcSEcCtD
Alfentanil—CYP3A4—Metabolism—HS3ST5—melanoma	9.5e-06	0.000412	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—FASN—melanoma	9.36e-06	0.000407	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—HPSE—melanoma	9.34e-06	0.000406	CbGpPWpGaD
Alfentanil—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	9.33e-06	0.000405	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GAB2—melanoma	9.3e-06	0.000404	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GNA11—melanoma	9.3e-06	0.000404	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FLT1—melanoma	9.26e-06	0.000402	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—SLC5A5—melanoma	9.21e-06	0.0004	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—RAC1—melanoma	9.2e-06	0.0004	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	9.17e-06	0.000398	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CUBN—melanoma	9.17e-06	0.000398	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	9.02e-06	0.000392	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MMP1—melanoma	8.9e-06	0.000387	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—GNAQ—melanoma	8.89e-06	0.000386	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CD44—melanoma	8.89e-06	0.000386	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	8.88e-06	0.000386	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—BSG—melanoma	8.85e-06	0.000385	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SDHD—melanoma	8.85e-06	0.000385	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CSPG4—melanoma	8.85e-06	0.000385	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCR4—melanoma	8.75e-06	0.00038	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HDAC2—melanoma	8.75e-06	0.00038	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FOXO4—melanoma	8.75e-06	0.00038	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—CDK2—melanoma	8.74e-06	0.000379	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—VCAN—melanoma	8.68e-06	0.000377	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—GNAQ—melanoma	8.65e-06	0.000376	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GPAM—melanoma	8.58e-06	0.000372	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	8.53e-06	0.00037	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—CYP1B1—melanoma	8.53e-06	0.00037	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.4e-06	0.000365	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CG—melanoma	8.33e-06	0.000362	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PLA2G6—melanoma	8.32e-06	0.000361	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	8.17e-06	0.000355	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SYK—melanoma	8.13e-06	0.000353	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—FN1—melanoma	8.12e-06	0.000353	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	8.12e-06	0.000352	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	8.06e-06	0.00035	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NOS2—melanoma	8.03e-06	0.000349	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	7.99e-06	0.000347	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	7.99e-06	0.000347	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ITGAV—melanoma	7.98e-06	0.000347	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NGFR—melanoma	7.98e-06	0.000347	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT3—melanoma	7.98e-06	0.000347	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CG—melanoma	7.77e-06	0.000338	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—EGF—melanoma	7.68e-06	0.000334	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.61e-06	0.00033	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.55e-06	0.000328	CbGpPWpGaD
Alfentanil—ALB—Metabolism—VCAN—melanoma	7.48e-06	0.000325	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SOCS1—melanoma	7.39e-06	0.000321	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAP2K1—melanoma	7.37e-06	0.00032	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—S100B—melanoma	7.37e-06	0.00032	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CD—melanoma	7.32e-06	0.000318	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP17A1—melanoma	7.32e-06	0.000318	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PLA2G6—melanoma	7.29e-06	0.000317	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLCB4—melanoma	7.2e-06	0.000313	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IGF1—melanoma	7.12e-06	0.000309	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.08e-06	0.000307	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB4—melanoma	7.05e-06	0.000306	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	7.04e-06	0.000306	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	7.03e-06	0.000305	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ABCB1—melanoma	7.02e-06	0.000305	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN2B—melanoma	6.99e-06	0.000303	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	6.94e-06	0.000301	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNA11—melanoma	6.92e-06	0.0003	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CD—melanoma	6.83e-06	0.000297	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.83e-06	0.000297	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC6A11—melanoma	6.77e-06	0.000294	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIP4K2A—melanoma	6.77e-06	0.000294	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—FASN—melanoma	6.77e-06	0.000294	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD86—melanoma	6.76e-06	0.000293	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—CXCL8—melanoma	6.76e-06	0.000293	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.71e-06	0.000291	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EDN1—melanoma	6.71e-06	0.000291	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—SLC5A5—melanoma	6.66e-06	0.000289	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—MTAP—melanoma	6.58e-06	0.000286	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF1—melanoma	6.55e-06	0.000285	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CSF2—melanoma	6.55e-06	0.000285	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—VCAN—melanoma	6.55e-06	0.000284	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PRKCA—melanoma	6.46e-06	0.000281	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—IL2—melanoma	6.46e-06	0.00028	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—GNAQ—melanoma	6.43e-06	0.000279	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CD44—melanoma	6.43e-06	0.000279	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—E2F1—melanoma	6.41e-06	0.000279	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ERCC2—melanoma	6.41e-06	0.000278	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CB—melanoma	6.38e-06	0.000277	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PDGFRA—melanoma	6.35e-06	0.000276	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP17A1—melanoma	6.31e-06	0.000274	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PRKCA—melanoma	6.28e-06	0.000273	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ITGB3—melanoma	6.28e-06	0.000273	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.22e-06	0.00027	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—CYP1B1—melanoma	6.16e-06	0.000268	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—SPP1—melanoma	6.16e-06	0.000268	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAP2K2—melanoma	6.14e-06	0.000267	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—CXCL8—melanoma	6.13e-06	0.000266	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNA11—melanoma	5.96e-06	0.000259	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CB—melanoma	5.96e-06	0.000259	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PHGDH—melanoma	5.87e-06	0.000255	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—LUM—melanoma	5.87e-06	0.000255	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL2—melanoma	5.86e-06	0.000255	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TERT—melanoma	5.84e-06	0.000254	CbGpPWpGaD
Alfentanil—ALB—Metabolism—FASN—melanoma	5.83e-06	0.000253	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—RAC1—melanoma	5.83e-06	0.000253	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—HPSE—melanoma	5.75e-06	0.00025	CbGpPWpGaD
Alfentanil—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	5.75e-06	0.00025	CbGpPWpGaD
Alfentanil—ALB—Metabolism—SLC5A5—melanoma	5.73e-06	0.000249	CbGpPWpGaD
Alfentanil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.67e-06	0.000246	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CUBN—melanoma	5.65e-06	0.000245	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HIF1A—melanoma	5.59e-06	0.000243	CbGpPWpGaD
Alfentanil—ALB—Metabolism—GNAQ—melanoma	5.54e-06	0.00024	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CD44—melanoma	5.54e-06	0.00024	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP17A1—melanoma	5.53e-06	0.00024	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—IL2—melanoma	5.47e-06	0.000238	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SDHD—melanoma	5.46e-06	0.000237	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—BSG—melanoma	5.46e-06	0.000237	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CSPG4—melanoma	5.46e-06	0.000237	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.42e-06	0.000235	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.37e-06	0.000233	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KDR—melanoma	5.34e-06	0.000232	CbGpPWpGaD
Alfentanil—ALB—Metabolism—CYP1B1—melanoma	5.31e-06	0.000231	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GPAM—melanoma	5.28e-06	0.000229	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNA11—melanoma	5.22e-06	0.000227	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FN1—melanoma	5.14e-06	0.000223	CbGpPWpGaD
Alfentanil—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	5.12e-06	0.000222	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—FASN—melanoma	5.11e-06	0.000222	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ABCB1—melanoma	5.08e-06	0.00022	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CG—melanoma	5.06e-06	0.00022	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NOTCH1—melanoma	5.03e-06	0.000219	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—SLC5A5—melanoma	5.02e-06	0.000218	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CD80—melanoma	4.93e-06	0.000214	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CG—melanoma	4.92e-06	0.000214	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—APC—melanoma	4.92e-06	0.000214	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KIT—melanoma	4.92e-06	0.000214	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—NRAS—melanoma	4.92e-06	0.000214	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PPARG—melanoma	4.89e-06	0.000212	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGF—melanoma	4.86e-06	0.000211	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—GNAQ—melanoma	4.85e-06	0.000211	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CD44—melanoma	4.85e-06	0.000211	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK3—melanoma	4.71e-06	0.000205	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.69e-06	0.000203	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PRKCA—melanoma	4.67e-06	0.000203	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—CYP1B1—melanoma	4.65e-06	0.000202	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—VEGFA—melanoma	4.65e-06	0.000202	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ERCC2—melanoma	4.63e-06	0.000201	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—BRAF—melanoma	4.63e-06	0.000201	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—NRAS—melanoma	4.59e-06	0.000199	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IGF1—melanoma	4.51e-06	0.000196	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PLA2G6—melanoma	4.49e-06	0.000195	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—MAPK1—melanoma	4.48e-06	0.000195	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—EGFR—melanoma	4.48e-06	0.000195	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CD—melanoma	4.45e-06	0.000193	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK3—melanoma	4.4e-06	0.000191	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—ALB—melanoma	4.39e-06	0.000191	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ABCB1—melanoma	4.37e-06	0.00019	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAP2K1—melanoma	4.36e-06	0.000189	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CD—melanoma	4.33e-06	0.000188	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	4.29e-06	0.000186	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—KRAS—melanoma	4.24e-06	0.000184	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—MAPK1—melanoma	4.18e-06	0.000182	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—FGF2—melanoma	4.14e-06	0.00018	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—VCAN—melanoma	4.04e-06	0.000175	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PRKCA—melanoma	4.02e-06	0.000175	CbGpPWpGaD
Alfentanil—ALB—Metabolism—ERCC2—melanoma	3.99e-06	0.000173	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—KRAS—melanoma	3.95e-06	0.000172	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—PIK3CA—melanoma	3.89e-06	0.000169	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CB—melanoma	3.88e-06	0.000168	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MDM2—melanoma	3.88e-06	0.000168	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTGS2—melanoma	3.84e-06	0.000167	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—ERBB2—melanoma	3.82e-06	0.000166	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CB—melanoma	3.77e-06	0.000164	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CG—melanoma	3.66e-06	0.000159	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—PIK3CA—melanoma	3.63e-06	0.000158	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CXCL8—melanoma	3.62e-06	0.000157	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—HRAS—melanoma	3.6e-06	0.000156	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1B—melanoma	3.54e-06	0.000154	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PPARG—melanoma	3.53e-06	0.000153	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PRKCA—melanoma	3.53e-06	0.000153	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—TP53—melanoma	3.51e-06	0.000153	CbGpPWpGaD
Alfentanil—OPRM1—GPCR downstream signaling—AKT1—melanoma	3.5e-06	0.000152	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ERCC2—melanoma	3.5e-06	0.000152	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CASP3—melanoma	3.47e-06	0.000151	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL2—melanoma	3.46e-06	0.00015	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—IL6—melanoma	3.45e-06	0.00015	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP17A1—melanoma	3.4e-06	0.000148	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CCND1—melanoma	3.38e-06	0.000147	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—HRAS—melanoma	3.36e-06	0.000146	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PTEN—melanoma	3.35e-06	0.000146	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CTNNB1—melanoma	3.34e-06	0.000145	CbGpPWpGaD
Alfentanil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.31e-06	0.000144	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MMP9—melanoma	3.28e-06	0.000142	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—CDKN1A—melanoma	3.27e-06	0.000142	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PTEN—melanoma	3.26e-06	0.000142	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NFKB1—melanoma	3.24e-06	0.000141	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CD—melanoma	3.22e-06	0.00014	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNA11—melanoma	3.22e-06	0.00014	CbGpPWpGaD
Alfentanil—OPRM1—Signaling by GPCR—AKT1—melanoma	3.18e-06	0.000138	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—ALB—melanoma	3.18e-06	0.000138	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CG—melanoma	3.15e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—FASN—melanoma	3.15e-06	0.000137	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—SLC5A5—melanoma	3.09e-06	0.000134	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PPARG—melanoma	3.04e-06	0.000132	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CD44—melanoma	2.99e-06	0.00013	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—GNAQ—melanoma	2.99e-06	0.00013	CbGpPWpGaD
Alfentanil—ALB—Hemostasis—AKT1—melanoma	2.97e-06	0.000129	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—VEGFA—melanoma	2.94e-06	0.000128	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—STAT3—melanoma	2.91e-06	0.000127	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—NRAS—melanoma	2.91e-06	0.000126	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—CYP1B1—melanoma	2.87e-06	0.000124	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CB—melanoma	2.8e-06	0.000122	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK3—melanoma	2.78e-06	0.000121	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTGS2—melanoma	2.78e-06	0.000121	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CD—melanoma	2.77e-06	0.00012	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CG—melanoma	2.76e-06	0.00012	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MYC—melanoma	2.71e-06	0.000118	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PPARG—melanoma	2.66e-06	0.000116	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—MAPK1—melanoma	2.65e-06	0.000115	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—EGFR—melanoma	2.65e-06	0.000115	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—KRAS—melanoma	2.5e-06	0.000109	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CD—melanoma	2.43e-06	0.000105	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PTEN—melanoma	2.42e-06	0.000105	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CB—melanoma	2.41e-06	0.000105	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—ALB—melanoma	2.4e-06	0.000104	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTGS2—melanoma	2.39e-06	0.000104	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—PIK3CA—melanoma	2.36e-06	0.000103	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ABCB1—melanoma	2.36e-06	0.000102	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—PIK3CA—melanoma	2.3e-06	9.98e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—TP53—melanoma	2.22e-06	9.66e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PRKCA—melanoma	2.17e-06	9.43e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ERCC2—melanoma	2.15e-06	9.35e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—HRAS—melanoma	2.13e-06	9.24e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CB—melanoma	2.12e-06	9.19e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTGS2—melanoma	2.1e-06	9.1e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PTEN—melanoma	2.09e-06	9.06e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—IL6—melanoma	2.04e-06	8.84e-05	CbGpPWpGaD
Alfentanil—CYP3A7—Metabolism—AKT1—melanoma	1.93e-06	8.39e-05	CbGpPWpGaD
Alfentanil—OPRM1—Signaling Pathways—AKT1—melanoma	1.88e-06	8.16e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PTEN—melanoma	1.83e-06	7.94e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—PIK3CA—melanoma	1.71e-06	7.42e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CG—melanoma	1.7e-06	7.39e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PPARG—melanoma	1.64e-06	7.13e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CD—melanoma	1.5e-06	6.49e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—ALB—melanoma	1.48e-06	6.41e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—PIK3CA—melanoma	1.47e-06	6.39e-05	CbGpPWpGaD
Alfentanil—CYP3A5—Metabolism—AKT1—melanoma	1.4e-06	6.06e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CB—melanoma	1.3e-06	5.66e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTGS2—melanoma	1.29e-06	5.61e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—PIK3CA—melanoma	1.29e-06	5.6e-05	CbGpPWpGaD
Alfentanil—ALB—Metabolism—AKT1—melanoma	1.2e-06	5.22e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PTEN—melanoma	1.13e-06	4.89e-05	CbGpPWpGaD
Alfentanil—ABCB1—Metabolism—AKT1—melanoma	1.05e-06	4.58e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—PIK3CA—melanoma	7.95e-07	3.45e-05	CbGpPWpGaD
Alfentanil—CYP3A4—Metabolism—AKT1—melanoma	6.49e-07	2.82e-05	CbGpPWpGaD
